X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
oncology (6) 6
cancer (5) 5
female (5) 5
head and neck neoplasms - drug therapy (5) 5
male (5) 5
aged (4) 4
carcinoma, squamous cell - drug therapy (4) 4
head and neck neoplasms - pathology (4) 4
index medicus (4) 4
middle aged (4) 4
adult (3) 3
antineoplastic agents - therapeutic use (3) 3
chemotherapy (3) 3
head and neck cancer (3) 3
metastasis (3) 3
methotrexate (3) 3
neoplasm recurrence, local - drug therapy (3) 3
phase-ii trial (3) 3
treatment outcome (3) 3
trial (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
carcinoma, squamous cell - pathology (2) 2
disease-free survival (2) 2
drug therapy (2) 2
hematology (2) 2
hematology, oncology and palliative medicine (2) 2
human medicine (2) 2
induction chemotherapy (2) 2
methotrexate - administration & dosage (2) 2
nasopharyngeal carcinoma (2) 2
neoplasm metastasis (2) 2
neoplasm recurrence, local - pathology (2) 2
quinazolines - administration & dosage (2) 2
solid tumors (2) 2
squamous cell carcinoma (2) 2
squamous cell carcinoma of head and neck (2) 2
tumor proteins (2) 2
9-nitro-camptothecin (1) 1
9-nitrocamptothecin rfs-2000 (1) 1
abridged index medicus (1) 1
activated protein-kinase (1) 1
adjuvant chemotherapy (1) 1
afatinib (1) 1
aged, 80 and over (1) 1
akt (1) 1
alkylating agents (1) 1
anaplastic (1) 1
angiogenesis inhibitors - pharmacology (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
anthracyclines (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
anticancer properties (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
biological products - therapeutic use (1) 1
biomarker (1) 1
biomedicine (1) 1
brief (1) 1
brief article (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - adverse effects (1) 1
camptothecin - analogs & derivatives (1) 1
camptothecin - therapeutic use (1) 1
cancer research (1) 1
cancer therapies (1) 1
cancer-cells (1) 1
carcinoma (1) 1
carcinoma - genetics (1) 1
carcinoma - metabolism (1) 1
carcinoma - pathology (1) 1
carcinoma - therapy (1) 1
carcinoma, squamous cell - mortality (1) 1
carcinoma, squamous cell - radiotherapy (1) 1
carcinoma, squamous cell - secondary (1) 1
care and treatment (1) 1
case report (1) 1
cetuximab (1) 1
cetuximab - administration & dosage (1) 1
cetuximab - adverse effects (1) 1
cetuximab - therapeutic use (1) 1
chemoradiotherapy (1) 1
chemoradiotherapy - methods (1) 1
chemotherapy plus cetuximab (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
clinical study (1) 1
clinical trials (1) 1
colony-stimulating factor (1) 1
concurrent chemoradiotherapy (1) 1
continuous-infusion (1) 1
cooperative-oncology-group (1) 1
criteria (1) 1
dermatofibrosarcoma protuberans (1) 1
disease progression (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 583 - 594
Journal Article
by Cohen, Ezra E W and Cohen, Ezra and Soulières, Denis and Le Tourneau, Christophe and Dinis, Jose and Dinis, José and Licitra, Lisa and Ahn, Myung-Ju and Soria, Ainara and Machiels, Jean-Pascal and Mach, Nicolas and Mehra, Ranee and Burtness, Barbara Ann and Burtness, Barbara and Zhang, Pingye and Cheng, Jonathan and Swaby, Ramona F and Harrington, Kevin and Harrington, Kevin J and Acosta-Rivera, Mirelis and Adkins, Douglas R and Aghmesheh, Morteza and Airoldi, Mario and Aleknavicius, Eduardas and Al-Farhat, Yousuf and Algazi, Alain P and Almokadem, Salah and Alyasova, Anna and Bauman, Jessica R and Benasso, Marco and Berrocal, Alfonso and Bray, Victoria and Caponigro, Francesco and Castro, Ana and Cescon, Terrence P and Chan, Kelvin and Chaudhry, Arvind and Chauffert, Bruno and Csoszi, Tibor and De Boer, J.P and Delord, Jean-Pierre and Dietz, Andreas and Dupuis, Charlotte and Digue, Laurence and Erfan, Jozsef and Escobar Alvarez, Yolanda and Evans, Mererid and Fidler, Mary Jo and Forster, Martin David and Friesland, Signe and Ganti, Apar K and Geoffrois, Lionnel and Grant, Cliona and Gruenwald, Viktor and Hoffmann, Thomas and Horvai, Geza and Inciura, Arturas and Jang, Raymond and Jankowska, Petra and Jimeno, Antonio and Joseph, Mano and Juarez Ramiro, Alejandro and Karaszewska, Boguslawa and Kawecki, Andrzej and Keilholz, Ulrich and Keller, Ulrich and Kim, Sung-Bae and Kocsis, Judit and Kotecki, Nuria and Kozloff, Mark F and Lambea, Julio and Landherr, Laszlo and Lantsukhay, Yuri and Lazarev, Sergey Alexandrovich and Lee, Lip Way and Lifirenko, Igor Dmitrievich and Martincic, Danko and Matorin, Oleg Vladmirovhich and McGrath, Margaret and Misiukiewicz, Krzysztof and Morris, John C and Mufazalov, Fagim Fanisovich and Niu, Jiaxin and Pamoorthy Srinivasan, Devraj and Perez Segura, Pedro and Rauch, Daniel and Ribeiro, Maria Leonor and Rodriguez, Cristina and Rolland, Frederic and Russo, Antonio and Ruzsa, Agnes and Sanches, Frederico and Shin, Sang-Won and Shtiveland, Mikhail and Soulieres, Denis and Specenier, Pol and Szekanecz, Eva and Szota, Judit and van Herpen, Carla M.L and Velez-Cortes, Hector A and ... and Keynote-040 Investigators and KEYNOTE-040 investigators
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10167, pp. 156 - 167
There are few effective treatment options for patients with recurrent or metastatic head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour... 
CRITERIA | TRIAL | MEDICINE, GENERAL & INTERNAL | NIVOLUMAB | CANCER | CHEMOTHERAPY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Docetaxel - adverse effects | Humans | Middle Aged | Squamous Cell Carcinoma of Head and Neck - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Cetuximab - therapeutic use | Cetuximab - adverse effects | Docetaxel - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Squamous Cell Carcinoma of Head and Neck - drug therapy | Female | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Disease Progression | Head and Neck Neoplasms - pathology | Methotrexate - adverse effects | Squamous Cell Carcinoma of Head and Neck - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cetuximab - administration & dosage | Methotrexate - administration & dosage | Aged | Methotrexate | Squamous cell carcinoma | Metastasis | Therapy | Toxicity | Perforation | Clinical trials | Oncology | Cancer therapies | Metastases | Skin cancer | Anticancer properties | Pembrolizumab | Randomization | Motivation | Platinum | Neck | Safety | Medical treatment | Fatigue | Hypothyroidism | Survival | Patients | Chemotherapy | Interactive systems | Large intestine | Head and neck cancer | Ligands | Tumors
Journal Article
Head & Neck, ISSN 1043-3074, 05/2015, Volume 37, Issue 5, pp. 763 - 770
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2014, Volume 94, Issue 1, pp. 55 - 63
Journal Article
World journal of clinical oncology, ISSN 2218-4333, 05/2013, Volume 4, Issue 2, pp. 47 - 51
To provide efficacy and safety data about the combined use of radiotherapy and chemo-radiotherapy in nasopharyngeal carcinoma (NPC). We reviewed data of 40... 
Nasopharyngeal carcinoma | Locally advanced disease | Induction chemotherapy | Adjuvant chemotherapy | Brief | Concurrent chemoradiotherapy
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2008, Volume 62, Issue 2, pp. 209 - 214
Journal Article
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 04/2003, Volume 195, Issue 1, pp. 139 - 150
High expression of the epidermal growth factor receptor (EGFR) has been implicated in the development of squamous‐cell carcinomas of head and neck (SCCHN).... 
Journal Article
World journal of clinical cases, ISSN 2307-8960, 07/2014, Volume 2, Issue 7, pp. 297 - 300
Nasopharyngeal carcinoma is rare in western countries, accounting for less than 1% of all malignancies. Despite prognosis is satisfactory for newly diagnosed,... 
Nasopharyngeal carcinoma | Surgery of metastases | Re-irradiation | Cetuximab | Undifferentiated | Case Report
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.